Sammaan Capital · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
RBI approval remains pending (application ~3 months old). While management is optimistic, any delay in regulatory clearances (RBI, SEBI) could postpone the strategic expansion plans and force continued reliance on the existing limited product suite.
The new co-ending regulations (effective January 1) require operationalizing arrangements with multiple bank partners. Management acknowledged first two quarters will be relatively slow, with return to original volume levels expected by May-June 2026. Any delay in technology integration or partner onboarding could impact fee income.
The Supreme Court proceedings on a 2019 PIL involving former promoter Samir Ghosh remain sub-judice. While CBI confirmed no loss to public monies and principal exposure is nil, media attention and regulatory scrutiny could create operational distractions and delay regulatory approvals.
Analyst directly asked for 2-3 year revenue projections, and management declined to provide any revenue guidance, stating strategic shift is imminent post-investment. This evasive response suggests potential near-term revenue visibility concerns that may concern investors seeking concrete forward-looking metrics.
